Vol 13, No 4 (August 01, 2024): Hepatobiliary Surgery and Nutrition

Original Article

The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy
Lu Lu, Wen-Wei Zhu, Cong-Huan Shen, Yi-Feng Tao, Zheng-Xin Wang, Jin-Hong Chen, Lun-Xiu Qin
ICG fluorescence cholangiography avoided the biliary complications in both donors and its relevant recipients and is recommended for routine use in LLLS.
Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma
Yiran Li, Ziyu Xun, Junyu Long, Huishan Sun, Xu Yang, Yanyu Wang, Yunchao Wang, Jingnan Xue, Nan Zhang, Junwei Zhang, Jin Bian, Jie Shi, Xiaobo Yang, Hanping Wang, Haitao Zhao
We used single-cell RNA sequencing data analysis to systematically compare the transcriptomic signatures of different cell populations in HCC, iCCA and H-ChC, which revealed the molecular mechanisms underlying the coexistence of HCC and iCCA components in H-ChC.
The differential benefit of laparoscopic over open minor liver resection for lesions situated in the anterolateral or posterosuperior segments
Jasper P. Sijberden, Guido Fiorentini, Jacopo Lanari, Davit Aghayan, Daniel Osei-Bordom, Nadia Russolillo, Arjun Takhar, Andrea Benedetti Cacciaguerra, Santi Lopez-Ben, Mathieu D’Hondt, Felice Giuliante, David Fuks, Fernando Rotellar, Andrea Ruzzenente, Adnan Alseidi, Mikhail Efanov, Burak Görgec, Giuseppe Zimmitti, Enrico Gringeri, Federica Cipriani, Åsmund Avdem Fretland, Ravi Marudanayagam, Marco Vivarelli, John N. Primrose, Alessandro Ferrero, Robert P. Sutcliffe, Bjørn Edwin, Umberto Cillo, Marc G. Besselink, Mohammad Abu Hilal, Luca A. Aldrighetti
Laparoscopic surgery offers several benefits over open surgery when adopted for minor liver resections in the AL and PS segments. The advantage of laparoscopy is however greater in the AL segments. In centers with the appropriate experience, the minimally invasive approach should thus increasingly be adopted to perform minor liver resections irrespective of the location of the lesion(s).
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study
Jingzhong Ouyang, Yi Yang, Yanzhao Zhou, Xu Chang, Zhengzheng Wang, Qingjun Li, Yu Tang, Jianqiang Cai, Jinxue Zhou, Zhen Huang, Hong Zhao
Camrelizumab plus Apatinib has shown significant efficacy in improving RFS as a postoperative adjuvant regimen for patients with MVI-positive HCC. The favorable safety makes the combination an alternative adjunctive regimen for HCC patients after hepatectomy.
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment
Ling Luo, Junzhao Ye, Shuyu Zhuo, Bo Ma, Weiyi Mai, Xiaopei Cao, Liuqin Liang, Wei Wang, Shiting Feng, Zhi Dong, Bihui Zhong
Residual insulin resistance and high total bile acid levels were identified as risk factors for subsequent diminished sustained improvements of steatosis and fibrosis in MASLD patients, respectively. This provides potential guidance for clinicians in preventing patients against loss of treatment response in MASLD.

Review Article

A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact
Ziyan Pan, Wai-Kay Seto, Chun-Jen Liu, Yilei Mao, Saleh A. Alqahtani, Mohammed Eslam
This review provides a comprehensive and updated review of research on the genetics and epigenetic mechanisms implicated in developing Hepatocellular carcinoma (HCC) associated with Hepatitis C infection (HCV) infection. We also discuss the potential translational implications, including novel biomarkers and drugs for treatment.

Surgical Technique

Beyond the Rex: an innovative meso-intrahepatic portal vein bypass for late-onset extrahepatic portal vein occlusion after living donor liver transplantation
Chee-Chien Yong, Hsu-Ting Yen, Yu-Fan Cheng, Leona Bettina Dungca, Raymond Joseph De Vera, Itsuko Chih-Yi Chen, Chao-Long Chen
The MIPVB is an innovative technique to address EHPVO especially in patients with a Rex recess that is not safely accessible and with symptoms refractory to conventional surgical strategies. Furthermore, it is potentially useful for the right liver graft.

Editorial Commentary

Does ischemia-free machine perfusion lead to early allograft dysfunction (EAD) free liver transplantation?
Hani M. Wadei, Kristopher P. Croome
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?
Damiano Patrono, Nicola De Stefano, Elena Vissio, Alessandro Gambella, Renato Romagnoli
Liver microbiome: an intrahepatic resident playing a role in liver diseases
Xindi Ke, Qiaoxin Wei, Lejia Sun, Huayu Yang
Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation
Ao Wen, Lingxiao Yang, Tao Lv, Huayu Yang, Fei Li, Yilei Mao, Gang Xu, Jia-Yin Yang
Critical appraisal of novel prediction models and risk calculators for post-hepatectomy liver failure and complications: practicability and generalisability in the real-world setting
Darren Weiquan Chua, Yun Zhao, Ye Xin Koh
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision
Massimo Primignani, Giulia Tosetti, Andrea Artoni
Minimally invasive liver resection in metabolic syndrome: insights and future directions
Kechun Wang, Yifan Li, Jinbo Gong, Mingda Wang, Tian Yang
Parenchymal sparing anatomical liver resections for hepatocellular carcinoma
Matteo Donadon, Guido Torzilli
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation
Chase J. Wehrle, Charles Miller, Koji Hashimoto, Andrea Schlegel
Understanding acute kidney injury (AKI) in liver cirrhosis from the acute-on-chronic liver failure (ACLF) perspective
Jeong-Ju Yoo, Sang Gyune Kim
Right or left hepatectomy: a continuing question in the era of pure laparoscopic donor hepatectomy
Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh
Pioneering the future of robotic liver surgery
Mohamed Elshaer
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines
Megan Vidal, Vladimir Neychev